Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Epiheart Oy
OY
Active
Y-tunnus 3107385-1
Haartmaninkatu 4, 00290
Helsinki
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2019
— employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Epiheart Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
3
1
5
14
7
Staff expenses
−46
−61
−101
−78
−49
EBITDA
−135
−115
−160
−102
−77
Depreciation & amort.
−22
−37
−57
−64
−81
EBIT
−156
−152
−217
−167
−158
Net financials
−1
−1
−36
−3
−6
Profit before tax
−158
−153
−253
−169
−165
Tax
−0
−0
−0
−0
−0
Net profit
−158
−153
−253
−169
−165
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
447
541
464
576
536
Equity
404
251
79
240
205
Long-term debt
—
254
318
318
239
Short-term debt
43
36
67
18
92
Total debt
43
290
385
336
331
Financial ratios
5-year trend
EBITDA-margin
-1093.6%
This company
15.8%
Market median
-7022% vs market
2021
2025
Soliditetsgrad
38.3%
This company
38.2%
Market median
+0% vs market
2021
2025
Egenkapitalforrentning
-80.2%
This company
18.4%
Market median
-536% vs market
2021
2025
Nettoresultatgrad
-2333.4%
This company
8.1%
Market median
-28907% vs market
2021
2025
Aktivomsætning
0.01×
This company
1.12×
Market median
-99% vs market
2021
2025
Gæld/egenkapital
1.61×
This company
0.62×
Market median
-160% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Epiheart Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network